# DITTO Daily

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ditto-daily

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.dittodaily.com
- Total disclosed funding: $6M
- Latest round: Seed (Jun 17, 2026)
- Investors on record: 2

## About

Based in the UK, DITTO Daily focuses on providing scientifically formulated daily supplements for menstrual health, aiming to alleviate symptoms associated with various menstrual conditions. Their products empower individuals by promoting wellness and enabling conversations about female health.Based in London, England, United Kingdom, and founded in 2024, DITTO Daily Ltd founded by Alice van der Schoot and Adam Kugler, provides science-backed nutritional supplements designed to support menstrual health and address symptoms associated with PMS, PMDD, PCOS, endometriosis, cramps, and hormonal health for the women's health and wellness industry. The company develops evidence-based consumer health products and invests in clinical research to improve solutions for menstrual cycle-related conditions.In July 2026, DITTO Daily raised EUR 5.2 million in seed funding co-led by FoodLabs and Eka Ventures.DITTO's primary offering is its Cycle Supplement, a scientifically formulated daily supplement designed to alleviate various menstrual cycle symptoms such as PMS, PMDD, PCOS, and endometriosis. The supplement combines a blend of ten nutrients, including Vitamin D, Zinc, Omega-3, Magnesium, and Calcium, with advanced nutrient delivery technology that allows for maximum absorption and gradual release of ingredients. This approach is intended to manage symptoms during menstruation and offer proactive support for menstrual health. DITTO products target individuals facing menstrual issues, particularly women, and are marketed in regions where female health and wellness products are in high demand, such as North America and Europe.DITTO generates revenue through a subscription model, allowing customers to receive their Cycle Supplements regularly. Clients can opt for flexible subscription plans that include options for pausing or skipping deliveries, enhancing customer retention. The business structure focuses on direct-to-consumer sales, enabling it to maintain a close connection with its clientele for feedback. The Cycle Supplement is competitively priced, appealing to a demographic that values health and wellness solutions tailored to menstrual health, supported by a 30-day money-back guarantee.The company will use the July 2026 funding to expand its supplement and conduct new clinical trials.

## Funding rounds

- Seed, Jun 17, 2026, $6M — Foodlabs, Eka Ventures

## Investors

- Foodlabs (https://capitalatlas.ai/funds/foodlabs) — Seed
- Eka Ventures (https://capitalatlas.ai/funds/eka-ventures) — Seed